FDA Approves Bemotrizinol, Enhancing U.S. Sunscreen Formulas with Advanced UV Protection
The FDA has approved bemotrizinol (BEMT), a chemical UV filter used in European and Asian sunscreens for over 20 years. This marks the first significant update to U.S. sunscreen formulas in decades. Bemotrizinol is known for its ability to absorb both UVA and UVB rays without breaking down easily in sunlight, offering more effective protection against skin cancer and wrinkles. Historically, U.S. sunscreens have lagged behind due to stringent regulatory processes, which classify them as non-prescription drugs. This has resulted in slower innovation compared to countries like the UK, South Korea, and Japan, where sunscreens are treated as cosmetics. The approval of bemotrizinol is expected to improve the efficacy and application of U.S. sunscreens, although it will take over a year for these new products to become available.